Corporate Information

• When was the company founded?

  It is August 9, 2005.

• When did the stock go public?

  In December 2012, it was listed on the Tokyo Stock Exchange Mothers, transferred to the First Section of the Tokyo Stock Exchange in December 2014, and moved to the Tokyo Stock Exchange Prime Market in April 2022.

• Which is the listed market?

  Tokyo Stock Exchange prime market.

• Please tell us about your company profile.

  Click here for details.

• Please tell me about the silent period.

  From the perspective of preventing the leakage of financial results information (including quarterly financial results information) and ensuring the fairness of information disclosure, we have designated a quiet period from the day following the closing date of financial results (quarterly financial results) to the day each financial results are announced.
  Click here for details.

• Where can I find information on past general meetings of shareholders?

  Click here for details.

• Where can I view past briefings for institutional investors and analysts?

  Click here for details.

• Can I automatically receive timely disclosure items?

  Please use the IR mail magazine registration. Company information uploaded to TDNET (timely disclosure information transmission system) will be automatically delivered to the registered address within 30 minutes.

• Where can I inquire about IR activities?

  Click here for contact information.

• Please tell me about group companies.

  Click here for details on each group company.

• When did you make Q'SAI Co., Ltd. a consolidated subsidiary?

  It will be from July 2021. Click here for details.

• Is it possible to visit Production Technology Research Institute?

  研究所の一般公開はしておりませんが、併設する八重山殖産では工場見学を受け入れております。
  企業研修や学校、教育関連の団体様はもちろん、個人の皆様からのご依頼もお受けしております。
  ユーグレナやクロレラにご興味のある方、ユーグレナ・グループの取り組みにご興味のある方はお気軽に「見学申し込みフォーム（八重山殖産ホームページ内）」よりお問い合わせください。
  皆様からのお申し込みをお待ちしております。
  (一部受け入れができない場合もございます。予めご了承下さい。工場見学についてご不明点がある場合は 「お問い合わせフォーム（八重山殖産ホームページ内）」よりご連絡下さい。)

Financial information

• When is the fiscal year end?

  End of December every year.

• When will the financial results be announced?

  We announce our financial results every quarter. Please see the IR Calendar for the schedule of future financial results announcements.

• Where can I get the latest financial information?

  Please use the IR Library.

• Can I see analyst reports?

  We utilize the services provided by Shared Research.
  Learn more about the report here.

• Do you have downloadable financial data?

  Click here for details.

Stock information

• What is your securities code?

  2931.

• How many shares are trading units?

  Units are 100 shares.

• Where is the shareholder registry administrator?

  三菱ＵＦＪ信託銀行株式会社です。
  ＜連絡先＞
  証券代行部テレホンセンター
  （受付時間：土日・祝祭日等を除く平日9:00～17:00）
  TEL:　0120-232-711（東京） / 0120-094-777（大阪）
  株式に関するお手続き（三菱UFJ信託銀行株式会社）

Shareholder return policy

• What is your dividend policy?

  At present, we believe that a rise in share price due to business growth will lead to maximization of shareholder returns.

• Please tell me about the shareholder benefit program.

  The purpose of this system is to express our appreciation for the daily support of our shareholders and to provide an opportunity for more people to understand the Group's products and services. Click here for details.

• Why did I receive a shareholder benefit for less than a year even though I have held shares for several years?

  If you are a shareholder who has held our company's shares for a long time and is using the stock lending system of a securities company, the stocks you hold will be on loan during the stock lending period, so there is a risk that they will not be considered as continuous holdings. Thank you. Shareholders using the stock lending system should be aware of this. For details, please check with the securities company where you have an account.

General business

• What is your segment?

  Our segments and main businesses are as follows.
  Healthcare business: Planning and sales of healthcare products such as foods and cosmetics, OEM supply, raw material development and production, etc.
  Biofuel business: R&D, manufacturing and sales of biofuel, development of technology for cultivating microalgae such as Euglena, etc.
  Other businesses: Manufacture and sale of organic compound fertilizers, gene analysis services, social business, research and development in new areas, etc.

Healthcare Business

• Please tell us about the characteristics of microalgae Euglena.

  Microalgae Euglena (Japanese name: Midori Mushi) are a type of algae like kelp and wakame seaweed. It is a small organism with a body length of approximately 30 µm to 50 µm, and has both the characteristics of a plant that performs photosynthesis and an animal that has flagella and is able to move freely. It is also utilized as a food resource because it contains 59 kinds of nutrients such as vitamins, minerals, amino acids, and unsaturated fatty acids, and as a biofuel resource because it produces fats and oils in its body.
  Euglena For more information about

• Can I purchase products containing Euglena?

  It is convenient to use our official mail order site. We are also preparing regular purchases that can be purchased at a discounted price. Click here for details.

Biofuel Business

• Please tell us about the current introduction of biofuels.

  2018年に神奈川県横浜市鶴見区にバイオ燃料実証プラントが竣工しました。この実証プラントにおいて、バイオジェット燃料、バイオディーゼル燃料などを製造しています。また陸・海・空の分野において合計93件を超える導入実績がございます。
  なお、実証プラントは実証フェーズの目標が成功裏に達成できたことを踏まえ2024年1月末で稼働終了し、商業化に向けた取組みに注力しております。

• Does Production Technology Research Institute in Ishigaki Island, Okinawa Prefecture produce biofuel?

  In Ishigaki City, Okinawa Prefecture, we mainly manufacture Euglena powder for health food and other healthcare businesses, but we do not manufacture biofuel.

• バイオ燃料事業の商業化プロジェクトとは何ですか？

  マレーシアのPETRONAS社、イタリアのEni社と3社共同で、マレーシアにおいて商業規模のバイオ燃料製造プラントを建設・運営するプロジェクトを推進しております。 2024年7月に最終投資決定を行い、同年9月に本商業プラントの建設・運営を担う合弁会社の設立・運営について定める株主間契約の締結を行いました。2024年中を目途として、マレーシアに本合弁会社を設立予定で、本合弁パートナー3社の連携のもと、バイオ燃料商業プラントの運営、バイオ燃料の製造・販売を進めてまいります。また、本商業プラントは2028年下期迄の稼働開始を目指しており、年間約65万トンの原料を処理、最大で日産1万2,500バレル（年産約72.5万キロリットル相当）のバイオジェット燃料・次世代バイオディーゼル燃料・バイオナフサ等のバイオ燃料を製造する能力を有する見通しです。
  詳細はこちらをご確認ください。